BackAdverum Biotechnologies Overview

Adverum Biotechnologies Total Assets

Adverum Biotechnologies's total assets is $72M.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$72.40M
↓ 69.11% YoYΔ $-161.97M vs prior year quarter

Peer trimmed avg / median

Loading

Adverum Biotechnologies Total Assets History

Loading

Adverum Biotechnologies vs. peers: Total Assets Comparison

Loading

Adverum Biotechnologies Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Adverum Biotechnologies (ADVM) FAQ

As of the most recent data (September 2025), ADVM shows a total assets of $72M. That compares with $230M in the prior-year period — down 69.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ADVM's total assets is now $72M (was $230M) — a 69.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Adverum Biotechnologies is outperforming or lagging.

Tracking ADVM's total assets over time shows whether Adverum Biotechnologies is scaling, shrinking, or reshaping that part of the business. The current reading is $72M That compares with $230M in the prior-year period — down 69.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has Adverum Biotechnologies's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $72M) with ownership activity and broader fundamentals.

Adverum Biotechnologies's total assets is $72M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.